Cor Vasa 2018, 60(3):e287-e295 | DOI: 10.1016/j.crvasa.2017.07.008

Echocardiography in patients with chronic kidney diseases

Jan Malík*, Vilém Danzig, Vladimíra Bednářová, Zdenka Hrušková
Kardionefrologická ambulance Komplexního kardiovaskulárního centra, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha, Česká republika

Vast majority of chronic kidney disease patients die from cardiovascular complications. Echocardiography is a fundamental method, which reveals many of them. They include especially dilatation and systolic dysfunction of the left ventricle and atrium, left ventricular hypertrophy, diastolic dysfunction of the left ventricle, heart calcification, which could lead up to the development of stenotic valvular disease, right ventricular dysfunction and pulmonary hypertension. Patients with chronic kidney failure differ from the general population by cyclic changes of hydration and by the presence of a low resistant arteriovenous shunt (hemodialysis access). These factors significantly affect the actual echocardiographic finding.

Keywords: Chronic kidney disease; Echocardiography; Heart failure; Pulmonary hypertension

Received: June 23, 2017; Accepted: July 29, 2017; Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malík J, Danzig V, Bednářová V, Hrušková Z. Echocardiography in patients with chronic kidney diseases. Cor Vasa. 2018;60(3):e287-295. doi: 10.1016/j.crvasa.2017.07.008.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. K.M. Andrassy, Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease', Kidney International 84 (2013) 622-623. Go to original source... Go to PubMed...
    2. R.N. Foley, A.J. Collins, End-stage renal disease in the United States: an update from the United States Renal Data System, Journal of the American Society of Nephrology 18 (2007) 2644-2648. Go to original source... Go to PubMed...
    3. L.S. Chawla, C.A. Herzog, M.R. Costanzo, et al., Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup, Journal of the American College of Cardiology 63 (2014) 1246-1252. Go to original source... Go to PubMed...
    4. L.J. Hickson, S.M. Negrotto, M. Onuigbo, et al., Echocardiography criteria for structural heart disease in patients with end-stage renal disease initiating hemodialysis, Journal of the American College of Cardiology 67 (2016) 1173-1182. Go to original source... Go to PubMed...
    5. A. Pluta, P. Strozecki, M. Krintus, et al., Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3, Renal Failure 37 (2015) 1105-1110. Go to original source... Go to PubMed...
    6. M. Park, C.Y. Hsu, Y. Li, et al., Associations between kidney function and subclinical cardiac abnormalities in CKD, Journal of the American Society of Nephrology 23 (2012) 1725-1734. Go to original source... Go to PubMed...
    7. B. Hewing, A.M. Dehn, O. Staeck, et al., Improved left ventricular structure and function after successful kidney transplantation, Kidney & Blood Pressure Research 41 (2016) 701-709. Go to original source... Go to PubMed...
    8. G.M. London, M.E. Safar, B. Pannier, Aortic aging in ESRD: structural, hemodynamic, and mortality implications, Journal of the American Society of Nephrology 27 (2016) 1837-1846. Go to original source... Go to PubMed...
    9. A. Linhart, S. Magage, T. Palecek, J. Bultas, Cardiac involvement in Fabry disease, Acta Paediatrica Supplement 91 (2002) 15-20. Go to original source...
    10. M. Leifheit-Nestler, R. Grosse Siemer, K. Flasbart, et al., Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease, Nephrology, Dialysis, Transplantation 31 (2016) 1088-1099. Go to original source... Go to PubMed...
    11. D.J. Kennedy, D. Malhotra, J.I. Shapiro, Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling, Cellular and Molecular Biology 52 (2006) 3-14.
    12. R.M. Lang, L.P. Badano, V. Mor-Avi, et al., Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, European Heart Journal Cardiovascular Imaging 16 (2015) 233-270. Go to original source... Go to PubMed...
    13. J. Filipovský, J. Widimský Jr., J. Špinar, Summary of 2013 ESH/ESC guidelines for the management of arterial hypertension, Cor et Vasa 56 (2014) e494-e518. Go to original source...
    14. E. Paoletti, L. De Nicola, F.B. Gabbai, et al., Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension, Clinical Journal of the American Society of Nephrology 11 (2016) 271-279. Go to original source... Go to PubMed...
    15. I.M. Mostovaya, M.L. Bots, M.A. van den Dorpel, et al., Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST), PLOS ONE 9 (2014) e84587. Go to original source... Go to PubMed...
    16. A. Odudu, M.T. Eldehni, G.P. McCann, et al., Characterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysis, European Radiology 26 (2016) 2749-2761. Go to original source... Go to PubMed...
    17. C.W. McIntyre, J.O. Burton, N.M. Selby, et al., Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow, Clinical Journal of the American Society of Nephrology 3 (2008) 19-26. Go to original source... Go to PubMed...
    18. J.O. Burton, H.J. Jefferies, N.M. Selby, C.W. McIntyre, Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function, Clinical Journal of the American Society of Nephrology 4 (2009) 1231-1925. Go to original source... Go to PubMed...
    19. H.J. Jefferies, J.O. Burton, C.W. McIntyre, Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability, Blood Purification 32 (2011) 63-68. Go to original source... Go to PubMed...
    20. R.M. Lang, L.P. Badano, V. Mor-Avi, et al., Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Journal of the American Society of Echocardiography 28 (2015) 1-39 e14. Go to original source... Go to PubMed...
    21. S.F. Nagueh, O.A. Smiseth, C.P. Appleton, et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, European Heart Journal Cardiovascular Imaging 17 (2016) 1260-1321. Go to original source... Go to PubMed...
    22. S.S. Han, G.Y. Cho, Y.S. Park, et al., Predictive value of echocardiographic parameters for clinical events in patients starting hemodialysis, Journal of Korean Medical Science 30 (2015) 44-53. Go to original source... Go to PubMed...
    23. L. Hee, T. Nguyen, M. Whatmough, Left atrial volume and adverse cardiovascular outcomes in unselected patients with and without CKD, Clinical Journal of the American Society of Nephrology 9 (2014) 1369-1376. Go to original source... Go to PubMed...
    24. J. Malik, J. Lachmanova, J. Kudlicka, et al., Left atrial dysfunction in end-stage renal disease patients treated by hemodialysis, Nephron 133 (2016) 169-174. Go to original source... Go to PubMed...
    25. A. Linhart, T. Paleček, Echokardiografie u nemocných s plicní hypertenzí, Praha: Maxdorf, 2016.
    26. Z. Li, X. Liang, S. Liu, et al., Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity, PLOS ONE 9 (2014) e114392. Go to original source... Go to PubMed...
    27. U.A. Sharaf El Din, M.M. Salem, D.O. Abdulazim, Is fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review, Journal of Advanced Research 8 (2017) 271-278. Go to original source... Go to PubMed...
    28. M.L. Lu, S. Gupta, A. Romero-Corral, et al., Cardiac calcifications on echocardiography are associated with mortality and stroke, Journal of the American Society of Echocardiography 29 (2016) 1171-1178. Go to original source... Go to PubMed...
    29. A.L. Klein, S. Abbara, D.A. Agler, et al., American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography, Journal of the American Society of Echocardiography 26 (2013) 965-1012 e15. Go to original source... Go to PubMed...
    30. R.L. Kleynberg, V.M. Kleynberg, L.M. Kleynberg, D. Farahmandian, Chronic constrictive pericarditis in association with end-stage renal disease, International Journal of Nephrology 2011 (2011) 469602. Go to original source... Go to PubMed...
    31. T. Palecek, L. Skalicka, J. Lachmanova, et al., Effect of preload reduction by hemodialysis on conventional and novel echocardiographic parameters of left ventricular structure and function, Echocardiography 25 (2008) 162-168. Go to original source... Go to PubMed...
    32. J. Malik, J. Kudlicka, V. Tesar, A. Linhart, Cardiac safety in vascular access surgery and maintenance, Contributions to Nephrology 184 (2015) 75-86. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes